About LivaNova PLC
LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing. The CRM business unit develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failure. CRM offers products, including leads and delivery systems, and information systems. The Neuromodulation business unit designs, develops and markets neuromodulation-based medical devices for the treatment of epilepsy and depression. Through the Neuromodulation business unit, the Company markets its implantable VNS Therapy systems that deliver vagus nerve stimulation therapy for the treatment of epilepsy and depression.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: LIVN
- Previous Close: $48.98
- 50 Day Moving Average: $47.38
- 200 Day Moving Average: $52.38
- 52-Week Range: $48,838,000.00 - $40.83
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 14.40
- P/E Growth: 1.15
- Market Cap: $2.40B
- Outstanding Shares: 48,838,000
- Beta: 0.7
- Net Margins: -5.51%
- Return on Equity: 4.42%
- Return on Assets: 3.15%
Companies Related to LivaNova PLC:
- Debt-to-Equity Ratio: 0.05%
- Current Ratio: 2.04%
- Quick Ratio: 1.42%
What is LivaNova PLC's stock symbol?
LivaNova PLC trades on the NASDAQ under the ticker symbol "LIVN."
Where is LivaNova PLC's stock going? Where will LivaNova PLC's stock price be in 2017?
5 analysts have issued twelve-month price objectives for LivaNova PLC's shares. Their predictions range from $54.00 to $70.00. On average, they expect LivaNova PLC's stock price to reach $62.50 in the next twelve months.
When will LivaNova PLC announce their earnings?
LivaNova PLC is scheduled to release their next quarterly earnings announcement on Monday, February, 20th 2017.
Who owns LivaNova PLC stock?
LivaNova PLC's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Franklin Resources Inc. (9.24%), FMR LLC (5.64%), FIL Ltd (5.51%), Columbia Wanger Asset Management LLC (4.22%), Renaissance Technologies LLC (3.28%) and State Street Corp (2.14%). Company insiders that own LivaNova PLC stock include Alfred J Novak, Daniel Jeffrey Moore, Hugh M Morrison, Jacques Gutedel and Two SCA Equinox.
Who sold LivaNova PLC stock? Who is selling LivaNova PLC stock?
LivaNova PLC's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Columbia Wanger Asset Management LLC, Institutional Capital LLC, Two Sigma Investments LP, Marshall Wace LLP, Guggenheim Capital LLC, Calamos Advisors LLC and Teachers Retirement System of The State of Kentucky. Company insiders that have sold LivaNova PLC stock in the last year include Alfred J Novak, Daniel Jeffrey Moore, Hugh M Morrison, Jacques Gutedel and Two SCA Equinox.
Who bought LivaNova PLC stock? Who is buying LivaNova PLC stock?
LivaNova PLC's stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Franklin Resources Inc., Paulson & CO. Inc., Credit Agricole S A, Third Avenue Management LLC, FIL Ltd, Allianz Asset Management AG and State Street Corp.
How do I buy LivaNova PLC stock?
Shares of LivaNova PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of LivaNova PLC stock cost?
One share of LivaNova PLC stock can currently be purchased for approximately $49.24.